📄 cardiovascular medicine

Gene-exposure interactions regulate cytokine-mediated chronic inflammation and cardiac remodeling

This study of nearly half a million UK Biobank participants reveals that chronic systemic inflammation, driven by gene-environment interactions and mediated by cytokines like IL-1 receptor antagonist, leads to restrictive cardiac remodeling and significantly increases the risk of major adverse cardiovascular events.

Original authors: Coriano, M., Tahasildar, S., Huang, L., Rjoob, K., Kalaie, S., Zheng, J., Curran, L., Gifani, P., Dumas, M.-E., O'Regan, D. P.

Published 2026-01-22

📖 5 min read🧠 Deep dive

CC BY 4.0

Original authors: Coriano, M., Tahasildar, S., Huang, L., Rjoob, K., Kalaie, S., Zheng, J., Curran, L., Gifani, P., Dumas, M.-E., O'Regan, D. P.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Imagine your body is a bustling city. In this city, chronic inflammation is like a low-level, never-ending smog that hangs over everything. For a long time, doctors knew this smog was bad for the heart, but they didn't fully understand how it was damaging the city's engine or what specific factors were making the smog worse.

This study, using data from nearly half a million people in the UK, acts like a massive detective investigation to map out exactly how this "smog" changes the heart's structure and who is most at risk.

Here is the breakdown of their findings in everyday terms:

1. The "Smog" and the Heart's Shape

The researchers measured a specific marker in the blood called GlycA. Think of GlycA as a "smog meter" that tells you how much chronic inflammation is floating around in your system.

They found that people with high levels of this "smog" have hearts that look different than healthy hearts.

The Analogy: Imagine a balloon. A healthy heart is like a well-inflated balloon that can stretch and fill up with air (blood) easily. In people with high inflammation, the heart becomes like a stiff, shrunken balloon.
What happened: The main chambers of the heart (the ventricles) got smaller and tighter. The walls got thicker. The heart couldn't fill up with as much blood as it used to.
The Compensation: Because the heart couldn't hold as much blood, it started beating faster to try to keep up, similar to a car engine revving higher to go the same speed because the gears are stuck.

2. The "Messengers" (Proteins)

The study didn't just stop at saying "smog is bad." They asked: Who is delivering the bad news to the heart?

They looked at 80 different proteins (chemical messengers) in the blood. They found that these messengers act like construction foremen telling the heart to change its shape.

The Key Foreman: One specific messenger, called IL-1 receptor antagonist (IL-1RA), was responsible for about 27% of the heart shrinking. It's like a foreman shouting, "Make the walls thicker and the room smaller!"
Other Messengers: Other proteins, like HGF and IL-6, were also found to be directing these changes, essentially rewriting the heart's blueprint to be smaller and stiffer.

3. What Creates the "Smog"? (The Exposome)

The researchers then asked: What is causing the smog in the first place? They looked at hundreds of environmental factors, from what people eat to where they live.

They found the strongest "smog generators" were:

Body Fat: Specifically, fat stored around the trunk (the belly area) and deep inside the body (visceral fat). This is like a factory constantly pumping out smoke.
Smoking: Current smokers had significantly higher smog levels.
Stress and Money: People with lower incomes, those renting from local authorities, and those reporting psychological distress or depression had higher inflammation.
The Good News: Things like having a higher income, eating oily fish, eating fruit, and exercising vigorously were like "air filters" that cleaned up the smog.

4. The "Genetic Switch" (Gene-Environment Interaction)

This is perhaps the most fascinating part. The study found that your genes act like a dimmer switch for how much your environment affects your inflammation.

The Analogy: Imagine two people are exposed to the same amount of stress or pollution.
- Person A has a genetic "switch" set to low. The stress makes them slightly inflamed, but not much.
- Person B has a genetic "switch" set to high. The exact same stress causes a massive spike in inflammation.
The Finding: The study showed that people with a higher genetic risk for heart disease or diabetes were much more sensitive to environmental triggers. For example, if someone with high genetic risk felt depressed, their inflammation levels skyrocketed much more than someone with low genetic risk feeling the same depression.

5. The Final Outcome: Heart Attacks and Death

Finally, they tracked these people over time.

The Result: People with the highest "smog meter" readings (GlycA) were 43% more likely to have a major heart event (like a heart attack, stroke, or heart failure) compared to those with the lowest readings.
The Takeaway: This risk remained high even after accounting for cholesterol, blood pressure, and other traditional risk factors. The "smog" itself was an independent predictor of trouble.

Summary

In simple terms, this paper tells us that chronic inflammation acts like a slow-acting force that shrinks and stiffens the heart. This process is driven by specific chemical messengers in the blood. While things like belly fat, smoking, and stress create this inflammation, your DNA decides how strongly your body reacts to those stressors.

The study highlights that to protect your heart, you can't just look at cholesterol; you have to understand the complex mix of your environment, your lifestyle, and your genetic makeup.

Technical Summary: Gene-exposure interactions regulate cytokine-mediated chronic inflammation and cardiac remodeling

Problem Statement
Chronic low-grade inflammation is a recognized mediator of cardiovascular disease (CVD) and a predictor of adverse outcomes, independent of traditional lipid-based risk factors. However, the specific mechanisms linking systemic inflammation to cardiac remodeling in the general population remain incompletely understood. Previous studies have not systematically characterized inflammation-associated cardiac phenotypes at a population scale, nor have they comprehensively mapped the environmental drivers and genetic susceptibilities that modulate inflammatory responses. Furthermore, the specific circulating proteins that mediate the relationship between systemic inflammation, structural cardiac changes, and clinical outcomes (such as Major Adverse Cardiovascular Events, or MACE) have not been fully resolved.

Methodology
This study leveraged the UK Biobank (UKB) cohort, analyzing subsets of up to 488,079 participants with multi-omic profiling, cardiac magnetic resonance (CMR) imaging, and longitudinal outcome data.

Inflammation Quantification: Chronic inflammation was measured using Glycoprotein Acetyls (GlycA), a composite biomarker derived from nuclear magnetic resonance (NMR) spectroscopy, chosen for its stability and sensitivity to multiple inflammatory pathways.
Cardiac Phenotyping: In a subset of 70,809 participants, machine learning techniques were applied to CMR and electrocardiogram (ECG) data to extract 33 imaging-derived phenotypes (IDPs) and 16 ECG traits, quantifying cardiac structure, function, and vascular stiffness.
Proteomic Mediation: The study analyzed 80 inflammatory proteins (from the Olink Explore 3072 platform) in 52,503 participants. Mediation analysis was employed to determine the proportion of GlycA's effect on cardiac IDPs and MACE that was explained by specific protein pathways.
Exposome-Wide Association Study (XWAS): An XWAS was conducted on 478,941 participants to identify environmental determinants of inflammation. This involved 169 environmental exposures and 8 body composition measurements.
Gene-Environment Interactions: Multi-ancestry polygenic risk scores (PRS) for CVD, lipids, diabetes, hypertension, and stroke were used to assess interactions with environmental factors. These interactions were tested using multivariable linear regression for GlycA levels and Cox proportional hazards models for MACE.
Statistical Analysis: Associations were assessed using multivariable linear regression and Cox models, adjusted for confounders (age, sex, body surface area, ethnicity, etc.). Significance was determined using the Benjamini-Hochberg false discovery rate (FDR) method.

Key Contributions and Results

Inflammation-Driven Restrictive Cardiac Remodeling:
Higher GlycA levels were significantly associated with a restrictive cardiac remodeling phenotype. Specifically, elevated GlycA correlated with reduced left ventricular indexed end-diastolic volume (LVEDVi; $\beta = -2.09$ ) and stroke volume, accompanied by compensatory increases in heart rate ( $\beta = 1.38$ ) and global left ventricular wall thickness. This pattern persisted across sex, age, and diabetes status and was independent of hsCRP levels.
Proteomic Mediation of Cardiac Adaptation:
Among 80 inflammatory proteins, Interleukin-1 receptor antagonist (IL-1RA) mediated 27% of the GlycA effect on LVEDVi. Hepatocyte growth factor (HGF) mediated 29% of the effect on left ventricular end-systolic volume (LVESVi). These findings implicate IL-1, TNF, and IL-6 signaling pathways as key drivers of structural cardiac adaptation.
Prognostic Value for MACE:
GlycA was a robust independent predictor of incident MACE. Participants in the highest GlycA quintile had a 43% higher risk of MACE compared to the lowest quintile (adjusted HR 1.43). This association remained significant even after adjusting for lipid profiles, CMR-derived IDPs, and hsCRP. Mediation analysis revealed that 63 proteins mediated the GlycA-MACE association, with IL-6 and HGF showing the largest mediated effects.
Environmental Determinants:
The XWAS identified trunk fat mass ( $\beta = 0.35$ ), current smoking ( $\beta = 0.39$ ), psychological distress, and low socioeconomic status (e.g., renting from local authorities) as the strongest positive determinants of GlycA levels. Conversely, higher income and strenuous exercise were negatively associated with inflammation. Collectively, the top environmental exposures explained 18.6% of the variance in GlycA.
Gene-Environment Interactions:
Genetic susceptibility significantly modified the relationship between environmental exposures and inflammation. The study identified 115 significant exposure-PRS interactions modifying GlycA levels (101 remained significant after adjusting for deprivation index). For instance, the association between depressed mood and GlycA was amplified in individuals with higher genetic risk for type 2 diabetes. Similarly, genetic risk scores for CVD modified the impact of employment status on MACE risk.

Significance and Claims
The authors claim that this study provides the first large-scale, systematic assessment of the structural, proteomic, and environmental underpinnings of inflammatory risk. The findings advance the understanding of chronic inflammation as a driver of restrictive cardiac remodeling and adverse cardiovascular outcomes. By identifying specific cytokine mediators (such as IL-1RA and IL-6) and demonstrating that individual inflammatory responses are shaped by gene-environment interactions, the paper argues for a more nuanced approach to cardiovascular risk stratification. The authors suggest that these insights support the development of precision prevention strategies and the prioritization of therapeutic targets (specifically cytokine pathways) in risk-diverse populations. The study emphasizes that individual risk is determined by the convergence of inherited genetic susceptibility and acquired environmental factors.